A dopamine transport inhibitor with markedly low abuse liability suppresses cocaine self-administration in the rat (original) (raw)

• Agoston GE, Wu JH, Izenwasser S, George C, Katz J, Kline RH, Newman AH (1997) Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter. J Med Chem 40:4329–4339
  Article CAS PubMed Google Scholar
• Ahmed SH, Koob GF (2004) Changes in response to a dopamine receptor antagonist in rats with escalating cocaine intake. Psychopharmacology (Berl) 172:450–454
  Article CAS Google Scholar
• Beecher MD, Jackson DE (1976) Rate-dependent effect of amphetamine in rats: extension to between-subjects effect. Psychopharmacologia 46:307–309
  Article CAS PubMed Google Scholar
• Beuming T, Kniazeff J, Bergmann ML, Shi L, Gracia L, Raniszewska K, Newman AH, Javitch JA, Weinstein H, Gether U, Loland CJ (2008) The binding sites for cocaine and dopamine in the dopamine transporter overlap. Nat Neurosci 11:780–789
  Article CAS PubMed Google Scholar
• Botly LC, Burton CL, Rizos Z, Fletcher PJ (2008) Characterization of methylphenidate self-administration and reinstatement in the rat. Psychopharmacology (Berl) 199:55–66
  Article CAS Google Scholar
• Briscoe RJ, Vanecek SA, Vallett M, Baird TJ, Holloway FA, Gauvin DV (1998) Reinforcing effects of caffeine, ephedrine, and their binary combination in rats. Pharmacol Biochem Behav 60:685–693
  Article CAS PubMed Google Scholar
• Carrigan KA, Dykstra LA (2007) Behavioral effects of morphine and cocaine in M1 muscarinic acetylcholine receptor-deficient mice. Psychopharmacology (Berl) 191:985–993
  Article CAS Google Scholar
• Chen N, Reith ME (2007) Substrates and inhibitors display different sensitivity to expression level of the dopamine transporter in heterologously expressing cells. J Neurochem 101:377–388
  Article CAS PubMed Google Scholar
• Chen N, Zhen J, Reith ME (2004) Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine. J Neurochem 89:853–864
  Article CAS PubMed Google Scholar
• Crespo JA, Sturm K, Saria A, Zernig G (2006) Activation of muscarinic and nicotinic acetylcholine receptors in the nucleus accumbens core is necessary for the acquisition of drug reinforcement. J Neurosci 26:6004–6010
  Article CAS PubMed Google Scholar
• Dar DE, Mayo C, Uhl GR (2005) The interaction of methylphenidate and benztropine with the dopamine transporter is different than other substrates and ligands. Biochem Pharmacol 70:461–469
  Article CAS PubMed Google Scholar
• Davids E, Gastpar M (2004) Buprenorphine in the treatment of opioid dependence. Eur Neuropsychopharmacol 14:209–216
  Article CAS PubMed Google Scholar
• Desai RI, Kopajtic TA, French D, Newman AH, Katz JL (2005a) Relationship between in vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-{2-[bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine], and benztropine analogs. J Pharmacol Exp Ther 315:397–404
  Article CAS PubMed Google Scholar
• Desai RI, Kopajtic TA, Koffarnus M, Newman AH, Katz JL (2005b) Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine. J Neurosci 25:1889–1893
  Article CAS PubMed Google Scholar
• Dutta AK, Zhang S, Kolhatkar R, Reith ME (2003) Dopamine transporter as target for drug development of cocaine dependence medications. Eur J Pharmacol 479:93–106
  Article CAS PubMed Google Scholar
• Gorelick DA, Gardner EL, Xi ZX (2004) Agents in development for the management of cocaine abuse. Drugs 64:1547–1573
  Article CAS PubMed Google Scholar
• Grabowski J, Roache JD, Schmitz JM, Rhoades H, Creson D, Korszun A (1997) Replacement medication for cocaine dependence: methylphenidate. J Clin Psychopharmacol 17:485–488
  Article CAS PubMed Google Scholar
• Grabowski J, Shearer J, Merrill J, Negus SS (2004) Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addict Behav 29:1439–1464
  Article PubMed Google Scholar
• Harris RA, Snell D, Loh HH (1978) Effects of d-amphetamine, monomethoxyamphetamines and hallucinogens on schedule-controlled behavior. J Pharmacol Exp Ther 204:103–117
  CAS PubMed Google Scholar
• Hiranita T, Soto PL, Newman AH, Katz JL (2009) Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitors. J Pharmacol Exp Ther 329:677–686
  Article CAS PubMed Google Scholar
• Huang X, Zhan CG (2007) How dopamine transporter interacts with dopamine: insights from molecular modeling and simulation. Biophys J 93:3627–3639
  Article CAS PubMed Google Scholar
• Karila L, Gorelick D, Weinstein A, Noble F, Benyamina A, Coscas S, Blecha L, Lowenstein W, Martinot JL, Reynaud M, Lepine JP (2008) New treatments for cocaine dependence: a focused review. Int J Neuropsychopharmacol 11:425–438
  Article CAS PubMed Google Scholar
• Katz JL, Newman AH, Izenwasser S (1997) Relations between heterogeneity of dopamine transporter binding and function and the behavioral pharmacology of cocaine. Pharmacol Biochem Behav 57:505–512
  Article CAS PubMed Google Scholar
• Katz JL, Agoston GE, Alling KL, Kline RH, Forster MJ, Woolverton WL, Kopajtic TA, Newman AH (2001) Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodents. Psychopharmacology (Berl) 154:362–374
  Article CAS Google Scholar
• Katz JL, Kopajtic TA, Agoston GE, Newman AH (2004) Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands. J Pharmacol Exp Ther 309:650–660
  Article CAS PubMed Google Scholar
• Koob GF, Le HT, Creese I (1987) The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat. Neurosci Lett 79:315–320
  Article CAS PubMed Google Scholar
• Levin FR, Evans SM, Brooks DJ, Garawi F (2007) Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo. Drug Alcohol Depend 87:20–29
  Article CAS PubMed Google Scholar
• Li SM, Newman AH, Katz JL (2005) Place conditioning and locomotor effects of N-substituted, 4′, 4″-difluorobenztropine analogs in rats. J Pharmacol Exp Ther 313:1223–1230
  Article CAS PubMed Google Scholar
• Lile JA, Morgan D, Birmingham AM, Davies HM, Nader MA (2004) Effects of the dopamine reuptake inhibitor PTT on reinstatement and on food- and cocaine-maintained responding in rhesus monkeys. Psychopharmacology (Berl) 174:246–253
  Article CAS Google Scholar
• Lile JA, Wang Z, Woolverton WL, France JE, Gregg TC, Davies HM, Nader MA (2003) The reinforcing efficacy of psychostimulants in rhesus monkeys: the role of pharmacokinetics and pharmacodynamics. J Pharmacol Exp Ther 307:356–366
  Article CAS PubMed Google Scholar
• Loland CJ, Desai RI, Zou MF, Cao J, Grundt P, Gerstbrein K, Sitte HH, Newman AH, Katz JL, Gether U (2008) Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors. Mol Pharmacol 73:813–823
  Article CAS PubMed Google Scholar
• Minozzi S, Amato L, Davoli M, Farrell M, Lima Reisser AA, Pani PP, Silva de LM, Soares B, Vecchi S (2008) Anticonvulsants for cocaine dependence. Cochrane Database Syst Rev CD006754
• Negus SS, Mello NK, Lamas X, Mendelson JH (1996) Acute and chronic effects of flupenthixol on the discriminative stimulus and reinforcing effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 278:879–890
  CAS PubMed Google Scholar
• Negus SS, Mello NK, Kimmel HL, Howell LL, Carroll FI (2008) Effects of the monoamine uptake inhibitors RTI-112 and RTI-113 on cocaine- and food-maintained responding in rhesus monkeys. Pharmacol.Biochem.Behav
• Newman AH, Agoston GE (1998) Novel benztropine [3a-(diphenylmethoxy)tropane] analogs as probes for the dopamine transporter. Curr Med Chem 5:305–319
  CAS PubMed Google Scholar
• Orson FM, Kinsey BM, Singh RA, Wu Y, Gardner T, Kosten TR (2008) Substance abuse vaccines. Ann NY Acad Sci 1141:257–269
  Article CAS PubMed Google Scholar
• Preti A (2000) Vanoxerine National Institute on Drug Abuse. Curr Opin Investig Drugs 1:241–251
  CAS PubMed Google Scholar
• Raje S, Cao J, Newman AH, Gao H, Eddington ND (2003) Evaluation of the blood-brain barrier transport, population pharmacokinetics, and brain distribution of benztropine analogs and cocaine using in vitro and in vivo techniques. J Pharmacol Exp Ther 307:801–808
  Article CAS PubMed Google Scholar
• Raje S, Cornish J, Newman AH, Cao J, Katz JL, Eddington ND (2005) Pharmacodynamic assessment of the benztropine analogues AHN-1055 and AHN-2005 using intracerebral microdialysis to evaluate brain dopamine levels and pharmacokinetic/pharmacodynamic modeling. Pharm Res 22:603–612
  Article CAS PubMed Google Scholar
• Richardson NR, Roberts DC (1996) Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 66:1–11
  Article CAS PubMed Google Scholar
• Roberts DC (1993) Self-administration of GBR 12909 on a fixed ratio and progressive ratio schedule in rats. Psychopharmacology (Berl) 111:202–206
  Article CAS Google Scholar
• Rothman RB, Baumann MH, Prisinzano TE, Newman AH (2008) Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction. Biochem Pharmacol 75:2–16
  Article CAS PubMed Google Scholar
• Rush CR, Essman WD, Simpson CA, Baker RW (2001) Reinforcing and subject-rated effects of methylphenidate and d-amphetamine in non-drug-abusing humans. J Clin Psychopharmacol 21:273–286
  Article CAS PubMed Google Scholar
• Sagvolden T, Slatta K, Arntzen E (1988) Low doses of methylphenidate (Ritalin) may alter the delay-of-reinforcement gradient. Psychopharmacology (Berl) 95:303–312
  Article CAS Google Scholar
• Sanger DJ, Blackman DE (1976) Rate-dependent effects of drugs: a review of the literature. Pharmacol Biochem Behav 4:73–83
  Article CAS PubMed Google Scholar
• Sofuoglu M, Kosten TR (2005) Novel approaches to the treatment of cocaine addiction. CNS Drugs 19:13–25
  Article CAS PubMed Google Scholar
• Stafford D, Rice KC, Lewis DB, Glowa JR (2000) Response requirements and unit dose modify the effects of GBR 12909 on cocaine-maintained behavior. Exp Clin Psychopharmacol 8:539–548
  Article CAS PubMed Google Scholar
• Uchtenhagen A (2003) Substitution management in opioid dependence. J Neural Transm Suppl 33–60
• Ukairo OT, Bondi CD, Newman AH, Kulkarni SS, Kozikowski AP, Pan S, Surratt CK (2005) Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue. J Pharmacol Exp Ther 314:575–583
  Article CAS PubMed Google Scholar
• Vaughan RA, Agoston GE, Lever JR, Newman AH (1999) Differential binding of tropane-based photoaffinity ligands on the dopamine transporter. J Neurosci 19:630–636
  CAS PubMed Google Scholar
• Woolverton WL, Hecht GS, Agoston GE, Katz JL, Newman AH (2001) Further studies of the reinforcing effects of benztropine analogs in rhesus monkeys. Psychopharmacology (Berl) 154:375–382
  Article CAS Google Scholar